10-Q: Eastman Chemical Reports Q2 2025 Earnings Decline Amid Weak Demand and Unplanned Outage

Eastman Chemical Company reported a significant decline in second-quarter and first-half 2025 sales and earnings, primarily due to lower sales volume, reduced selling prices, and an unplanned outage in its Chemical Intermediates segment.

Summary

• Consolidated sales decreased by 3% to $2,287 million in Q2 2025 from $2,363 million in Q2 2024.
• Consolidated sales for the first six months of 2025 decreased by 2% to $4,577 million from $4,673 million in the same period of 2024.
• Gross profit declined by 16% to $506 million in Q2 2025 from $599 million in Q2 2024.
• Gross profit for the first six months of 2025 decreased by 5% to $1,073 million from $1,131 million in the same period of 2024.
• Earnings before interest and taxes (EBIT) decreased by 34% to $222 million in Q2 2025 from $337 million in Q2 2024.
• EBIT for the first six months of 2025 decreased by 13% to $524 million from $600 million in the same period of 2024.
• Net earnings attributable to Eastman fell to $140 million ($1.20 diluted EPS) in Q2 2025 from $230 million ($1.94 diluted EPS) in Q2 2024.
• Net earnings attributable to Eastman for the first six months of 2025 were $322 million ($2.77 diluted EPS) compared to $395 million ($3.33 diluted EPS) in the same period of 2024.
• Cash provided by operating activities significantly decreased to $66 million in the first six months of 2025 from $351 million in the first six months of 2024.
• The Chemical Intermediates segment experienced an approximately $20 million impact on EBIT from an unplanned outage.
• The Fibers segment saw sales revenue decrease by 17% in Q2 2025 and 15% in H1 2025 due to lower sales volume in acetate tow (destocking, industry capacity share adjustments) and lower textiles sales into China (global trade dispute).
• The Advanced Materials segment's sales decreased by 2% in Q2 2025 and 3% in H1 2025 due to weak primary demand in key end markets including building and construction and automotive.
• The Additives & Functional Products segment was the only segment to show sales growth, increasing by 7% in Q2 2025 and 6% in H1 2025, driven by higher selling prices and favorable product mix.

Sentiment

Score: 3

Explanation: The company reported significant declines across key financial metrics including sales, gross profit, EBIT, net earnings, and cash from operations for both the second quarter and first six months of 2025 compared to the prior year. This was driven by weak market demand, lower selling prices, higher costs, and an unplanned operational outage. While there are strategic investments and a strong credit facility, the immediate financial performance is concerning.

Positives

• Additives & Functional Products segment sales increased by 7% in Q2 2025 and 6% in H1 2025, driven by higher selling prices and favorable product mix, including care additives and heat transfer fluid project fulfillments.
• Selling, General and Administrative (SG&A) expenses decreased in Q2 and H1 2025 primarily due to lower variable compensation costs across segments.
• The company maintains a $1.50 billion revolving credit agreement, with no outstanding borrowings at June 30, 2025, indicating strong liquidity access.
• The company continues to pursue reinstatement of a terminated U.S. Department of Energy award for its Polyethylene Terephthalate Recycling Decarbonization Project.
• Share repurchases continued, with 643,791 shares bought back for $50 million in Q2/H1 2025, demonstrating a commitment to returning value to stockholders.

Negatives

• Consolidated sales decreased by 3% in Q2 2025 and 2% in H1 2025 compared to the prior year periods, primarily due to lower sales volume and lower selling prices.
• Consolidated EBIT excluding non-core items decreased by 22% in Q2 2025 and 7% in H1 2025, driven by lower sales volume, lower selling prices (net of higher raw material and energy costs), and higher maintenance costs.
• Net earnings attributable to Eastman significantly declined by 39% in Q2 2025 and 18% in H1 2025.
• Diluted EPS decreased by 38% in Q2 2025 and 17% in H1 2025.
• Cash provided by operating activities decreased by $285 million in H1 2025 compared to H1 2024, primarily due to lower accounts payable, lower net earnings, and higher variable compensation payout.
• The Chemical Intermediates segment experienced a significant decline in sales and EBIT, including an approximately $20 million impact from an unplanned outage.
• The Fibers segment saw substantial sales and EBIT decreases due to destocking, industry capacity share adjustments, and global trade disputes impacting sales into China.
• Advanced Materials segment sales decreased due to ongoing weak primary demand in key end markets like building and construction and automotive.
• Environmental and other costs from previously divested or non-operational sites increased to $40 million in H1 2025 from $16 million in H1 2024.
• Unrealized losses in Accumulated Other Comprehensive Income (AOCI) increased to $156 million at June 30, 2025, from a net unrealized gain of $154 million at December 31, 2024, primarily due to euro to U.S. dollar exchange rate changes.

Risks

• Global and regional economic, political, and business conditions, including heightened inflation, capital market volatility, interest rate and currency fluctuations, and economic slowdown or recession.
• Disruption or interruption of operations and of raw material or energy supply, including as a result of cyber-attacks or other breaches of information security systems.
• Impacts from U.S. tariffs, reciprocal tariffs, and global trade disruption, specifically affecting Fibers segment sales into China.
• Exposure to and effects of hedging raw material and energy prices and costs and foreign currency exchange and interest rates.
• Environmental matters and opportunities, including potential risks associated with physical and transitional impacts of climate change and related voluntary and regulatory carbon requirements, and costs for environmental remediation and closure/post-closure.
• Uncertainties related to environmental matters may have a material adverse effect on consolidated financial statements.
• Legal proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters.
• The U.S. Department of Energy terminated an award related to the Polyethylene Terephthalate Recycling Decarbonization Project, and the company is evaluating the impact on the project's scope, timeline, and carrying values of associated assets.

Future Outlook

The company expects 2025 capital expenditures to be approximately $550 million, primarily for targeted growth initiatives, including the Advanced Materials segment's methanolysis plastic-to-plastic molecular recycling manufacturing facilities, and site modernization projects. Management believes its innovation-driven growth model, combined with disciplined portfolio management and balanced capital deployment, will result in consistent, sustainable earnings growth and strong cash flow from operations.

Management Comments

• Management believes that these elements of the Company's innovation-driven growth model, combined with disciplined portfolio management and balanced capital deployment, will result in consistent, sustainable earnings growth and strong cash flow from operations.
• Management believes maintaining a financial profile that supports an investment grade credit rating is important to its long-term strategy and financial flexibility.
• Priorities for uses of available cash include capital expenditures, payment of the quarterly dividend, net debt reduction, and share repurchases.

Industry Context

The company's performance reflects continued weakness across key end markets, such as building and construction and automotive, and challenges like destocking and industry capacity share adjustments in the Fibers segment. Global trade disputes also impacted sales into China. This suggests a challenging macroeconomic environment affecting demand for chemical products.

Management Changes

Corporate Governance

Legal Proceedings

• The company is party to various lawsuits, claims, investigations, and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters.
• The company does not believe the ultimate resolution of these matters will have a material adverse effect on its overall financial position, results of operations, or cash flows.
• The company is involved in Solutia Legacy Torts Claims Litigation, where Monsanto Company (now Bayer AG) is responsible for defense and indemnification against certain claims.

Stakeholder Impact

• Shareholders: Experienced lower net earnings and diluted EPS, but the company continued cash dividends and share repurchases, indicating a commitment to returning value.
• Employees: Severance charges were incurred due to corporate cost reduction initiatives and the closure of a production line, indicating potential job impacts.
• Customers: Weak primary demand in key end markets (building and construction, automotive) and destocking by customers in the Fibers segment indicate reduced purchasing activity.
• Suppliers: The company works with suppliers to optimize payment terms and has a voluntary supplier finance program, which could affect supplier cash flow management.

Next Steps

• Continue evaluating the impact of the U.S. Department of Energy award termination on the Polyethylene Terephthalate Recycling Decarbonization Project's scope, timeline, and asset carrying values.
• Evaluate the potential impacts of the 'One Big Beautiful Bill Act' on federal income tax law, enacted on July 4, 2025.
• Expected capital expenditures of approximately $550 million for 2025, focusing on targeted growth initiatives and site modernization projects.
• Continue utilizing accounts receivable factoring programs and supplier finance programs for working capital management.
• Continue share repurchases under the 2021 authorization.

Key Dates

Recommendation

The company's Q2 and H1 2025 results show significant declines in sales, earnings, and cash flow, driven by broad market weakness, an operational outage, and specific segment challenges. While the Additives & Functional Products segment showed growth and the company maintains strong liquidity with its credit facility, the overall financial performance is concerning. Strategic investments in molecular recycling and ongoing cost reduction initiatives are positive long-term drivers, but the immediate outlook is challenged by persistent weak demand and increased environmental costs. An investor should hold to monitor the effectiveness of these strategic initiatives and a potential market recovery, but significant upside is unlikely in the short term given the current headwinds.

Keywords

Chemical manufacturing, specialty chemicals, advanced materials, additives, functional products, chemical intermediates, fibers, molecular recycling, sustainability, SEC filing, 10-Q, earnings report, financial results, corporate governance, risk management, capital expenditures, debt, share repurchase, environmental costs, supply chain, market demand